Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization

Nature Medicine

Volumn 6, Issue 5, 2000, Pages 599-602

  Sun, Liangwu ^a   Li, Juan ^a   Xiao, Xiao ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADENOVIRUS; CYSTIC FIBROSIS; DIMERIZATION; DNA PACKAGING; GENE SEQUENCE; GENE THERAPY; GENE TRANSFER; HEMOPHILIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SPLICING; TRANSGENE; VIRUS REPLICATION;

ANIMALS; DEPENDOVIRUS; DIMERIZATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LAC OPERON; MICE; MOLECULAR WEIGHT; RECOMBINANT PROTEINS; TRANSGENES;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; DNA VIRUSES;

EID: 0034121579     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/75087     Document Type: Review

References (24)

1. Kaplitt, M.G. et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154 (1994).
2. Xiao, X. et al. Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA(A) alpha1 containing receptors and increases inferior collicular seizure sensitivity. Brain Res. 756, 76-83 (1997).
3. Xiao, X. et al. Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy. J. Virol. 74, 1436-1442 (2000).
4. Xiao, X., Li, J. & Samulski, R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108 (1996).
5. Kessler, P.D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082-14087 (1996).
6. Flotte, T.R. et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc. Natl. Acad. Sci. USA 90, 10613-10617 (1993).
7. During, M.J. et al. In vivo expression of therapeutic human genes for dopamine production in the caudales of MPTP-treated monkeys using an AAV vector. Gene Ther. 5, 820-827 (1998).
8. Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270-276 (1997).
9. Xiao, W., Beta, S., Liu, M.M., Taxelaar, J. & Wilson, J.M. Adeno-associated virus as a vector for liver directed gene therapy. J. Virol. 72, 10222-10226 (1998).
10. Lewin, A.S. et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nature Med. 4, 967-971 (1998); erratum: 4, 1081 (1998).
11. Kay, M.A. et al Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nature Genet. 24 257-261 (2000).
12. Dong, J.Y., Fan, P.D. & Frizzell, R.A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101-2112 (1996).
13. Hoffman, E.P., Brown, R.H., Jr. & Kunkel, L.M. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928 (1987).
14. Liu, J. et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genet. 20, 31-36 (1998).
15. Flotte, T.R. et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268, 3781-3790 (1993).
16. Kotin, R M. & Berns, K.I. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170, 460-467 (1989).
17. Cheung, A.K., Hoggan, M.D., Hauswirth, W.W. & Berns, K.I. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33, 739-748 (1980).
18. McLaughlin, S.K., Collis, P., Hermonat, P.L. & Muzyczka, N. Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62, 1963-1973 (1988).
19. Duan, D. et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72, 8568-8577 (1998); erratum: 73, 861 (1999).
20. Talmadge, K., Vamvakopoulos, N.C. & Fiddes, J.C. Evolution of the genes for the beta subunits of human chorionic gonadotropin and luteinizing hormone. Nature 307, 37-40 (1984).
21. Xiao, X., Li, J. & Samulski, R.J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232 (1998).
22. Hirt, B. Selective extraction of polyoma DNA from infected mouse cultures. J. Mol. Biol. 26, 365-369 (1967).
23. Xiao, X., Xiao, W., Li, J. & Samulski, R.J. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 71, 941-948 (1997).
24. Duan, D., Yan, Z., Yue, Y. & Engelhardt, J.F. Structural analysis of adeno-associated virus transduction circular intermediates. Virology 261, 8-14 (1999).